Omri Amirav-Drory is a General Partner at NFX, whose known portfolio counts 16 companies.
Is Omri Amirav-Drory a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- AIHealthcareSaaS
Contacts
Affiliated funds' portfolios
General Partner at NFX, whose known portfolio counts 16 companies
- Starcloud
- Starfish Space
- Candex
- ImmuneBridge
- Q-Factor
- ScaleOps
- Novig
- Radar Therapeutics
- ResistanceBio
- CleverPet
- Gizmo
- Rexi
- and 4 more
Investor Profile
Omri Amirav-Drory is listed against sectors AI, Healthcare and SaaS, and focus areas Biotech, Developer Tools, Diagnostics and Drug Discovery in the database.
Stage-wise, the deals at NFX cluster around Growth, Pre-Seed and Seed rounds.
What the affiliated firm has backed is the closest available signal on whether Omri Amirav-Drory is worth approaching.
Colleagues at NFX
James Currier
General Partner
Palo Alto, United States
Pete Flint
General Partner
San Francisco, United States
Morgan Beller
General Partner
San Francisco, United States
Stan Chudnovsky
Co-Founder
United States
Gigi Levy-Weiss
General Partner
Israel
Brennan Lim
Fellow
San Francisco, United States
Anna Piñol
Partner
San Francisco, United States
Sarai Bronfeld
Partner
Tel Aviv-Yafo, Israel
Gita Bassman Reinitz
Investor
Israel
Katherine Cianciotti
Venture Capital
Cambridge, United States
Iman Abuzeid
Member
San Francisco, United States
Daniel Museles
Principal
United States
Anastasia Budinskaya
Investor
San Francisco, United States
Valerie Osband Mahoney
Principal
San Francisco, United States
Ann Lee Steinberg
Investor
San Francisco, United States
Frequently asked questions
Who is Omri Amirav-Drory?
Omri Amirav-Drory is a venture capital investor based in San Francisco, California, United States, listed as General Partner at NFX. The known portfolio of that firm counts 16 companies. That portfolio belongs to the firm, not to Omri Amirav-Drory personally.
What does Omri Amirav-Drory invest in?
Listed sectors include AI, Healthcare and SaaS; listed focus areas include Biotech, Developer Tools, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Omri Amirav-Drory invest at?
NFX appears in Growth, Pre-Seed and Seed rounds across its known deals, and Omri Amirav-Drory is listed there as General Partner. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Omri Amirav-Drory listed at?
Omri Amirav-Drory is listed as General Partner at NFX. 15 other people in the database share a firm with Omri Amirav-Drory.
How do I contact Omri Amirav-Drory?
An email address, a phone number and a LinkedIn page are on file for Omri Amirav-Drory. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal